Compare AHH & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AHH | BVS |
|---|---|---|
| Founded | 1979 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 532.2M | 482.9M |
| IPO Year | 2013 | 2021 |
| Metric | AHH | BVS |
|---|---|---|
| Price | $7.05 | $7.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $8.25 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 761.3K | 245.7K |
| Earning Date | 02-16-2026 | 11-04-2025 |
| Dividend Yield | ★ 7.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.19 | 0.15 |
| Revenue | $452,636,000.00 | ★ $563,829,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.97 | $7.11 |
| P/E Ratio | ★ $37.39 | $51.64 |
| Revenue Growth | N/A | ★ 1.58 |
| 52 Week Low | $6.01 | $5.81 |
| 52 Week High | $10.26 | $11.25 |
| Indicator | AHH | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 65.69 | 58.53 |
| Support Level | $6.83 | $7.56 |
| Resistance Level | $7.16 | $8.18 |
| Average True Range (ATR) | 0.15 | 0.31 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 84.21 | 75.96 |
Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.